Completed
A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers
NCT00911898
- Conditions
- Breast Diseases, Breast Neoplasms, Her2 Amplified Solid Tumors, +5 more
- Locations
-
- University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
- Indiana University (IUPUI) Indianapolis, Indiana, United States
- Fox Chase Center Philadelphia, Pennsylvania, United States
- South Texas Accelerated Research Therapeutics San Antonio, Texas, United States